Therapeutic Applications of Mesenchymal Stem Cell Secretome in Hair Regeneration

Abstract

Hair loss is a commonly encountered condition that often causes significant distress with diverse etiologies, including androgenic, autoimmune, inflammatory, and aging-related mechanisms. Current therapeutic options, such as minoxidil and finasteride, often exhibit limited efficacy and are associated with adverse effects, necessitating the exploration of safer and more effective alternatives. This review aims to explore the therapeutic potential of mesenchymal stem cell (MSC)-derived secretome as a novel cell-free approach for hair restoration. A narrative review of recent preclinical, in vivo, and early clinical studies was conducted to evaluate the role of MSC-secretome components, including growth factors, cytokines, extracellular vesicles, and exosomes, in modulating key pathways involved in the regeneration of hair follicles. In vitro and ex vivo models demonstrate that MSC-secretome enhances the proliferation, migration, and survival of dermal papilla cells and hair follicle stem cells by activation of the Wnt/β-catenin, IGF-1, VEGF, and PI3K/AKT signaling pathways via paracrine signaling. In vivo animal models of alopecia indicate accelerated anagen initiation, follicle reactivation, improved dermal papilla function, and reduced inflammatory mediators following treatment with MSC-conditioned medium or exosomes. Early clinical evidence, including topical MSC-conditioned medium application in alopecia areata, suggests improved follicular density and hair shaft thickness without significant adverse effects. In conclusion, MSC-derived secretome represents a promising, cell-free strategy for hair regeneration. Future research should prioritize optimizing production protocols, standardizing active components, validating potency assays, addressing regulatory and manufacturing challenges, and conducting well-designed clinical trials to ensure consistent therapeutic outcomes.